All stock lists
Ohmyhome Limited (NASDAQ:OMH)
SG · Delayed Price · Currency is USD
Real Estate · Real Estate - Services
13.39-2.15 (-13.86%)
Market cap
$6.17M
Insider Score
Health Score
Analyst consensus
Listed since
Mar 22, 2023
Website
Insider Score
––Not scored
OMH Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Fair
From OMH’s reported statements · Q2 2026 (trailing 12 months)
Profitability0 / 20
Loses money on what it sells.
- Revenue
- $15.6M
- Net income
- -$8.4M
- Net margin
- -54.0%
Leverage20 / 20
Little or no net debt.
- Total debt
- $0
- Cash
- $4.0M
- Debt / equity
- 0.00
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $4.1M
- Current liabilities
- $854K
- Current ratio
- 4.84
Cash generation0 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$3.7M
- Free cash flow
- -$4.0M
- FCF margin
- -25.4%
Dilution & runway8 / 20
Some dilution over the past year.
- Shares outstanding
- 0.5M
- Share growth (1y)
- 5.7%
- Cash runway
- 13 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
OMH Income Statement
| Fiscal Period | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Dec 31, 2025 | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 |
| Revenue | 1.93 M | 3.34 M | 3.94 M | 6.42 M | 4.47 M | 2.84 M |
| Revenue Growth (YoY) | -56.83 % | 17.58 % | 81.83 % | 76.11 % | 32.15 % | 37.66 % |
| Cost of Revenue | 1.76 M | 2.40 M | 3.32 M | 3.68 M | 2.80 M | 1.92 M |
| Gross Profit | 167.40 K | 940.28 K | 617.38 K | 2.74 M | 1.67 M | 916.01 K |
| SG&A Expense | 695.38 K | 4.90 M | 2.44 M | 3.74 M | 2.71 M | 3.87 M |
| R&D Expense | 0.00 | 0.00 | 449.84 K | 476.69 K | 788.96 K | 208.26 K |
| Operating Expenses | 620.96 K | 2.66 M | 1.65 M | 4.39 M | 4.40 M | 3.63 M |
| Operating Income | -453.56 K | -1.72 M | -1.03 M | -1.65 M | -2.73 M | -2.72 M |
| Pretax Income | -453.56 K | -4.25 M | -1.28 M | -2.08 M | -2.28 M | -3.02 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -860.05 K | -4.24 M | -1.27 M | -2.06 M | -2.28 M | -2.99 M |
| EPS (Basic) | -1.12 | -15.50 | -2.48 | -4.79 | -5.21 | -8.98 |
| EPS (Diluted) | -1.12 | -15.50 | -2.48 | -4.79 | -5.21 | -8.98 |
| Shares Outstanding | 462.05 K | 513.22 K | 513.22 K | 437.30 K | 437.30 K | 333.43 K |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.